Positive effects of renal denervation on markers of cardiovascular inflammation and left ventricular mass. 24-months follow-up

Aim. To study the long-term effect of renal denervation (RDN) on left ventricular mass (LVM) and inflammatory markers in resistant hypertensive patients.Material and methods. Forty-one patients with resistant hypertension and 24-h blood pressure (BP) 158,7±15,8/87,3+14,6 mmHg, aged 56,6+10,2 years,...

Full description

Saved in:
Bibliographic Details
Main Authors: E. S. Sitkova, V. F. Mordovin, S. E. Pekarskiy, T. M. Ripp, T. R. Ryabova, А. Yu. Falkovskaya, V. A. Lichikaki, I. V. Zyubanova, A. Е. Baev, A. M. Gusakova
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2021-03-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/2678
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849698911050006528
author E. S. Sitkova
V. F. Mordovin
S. E. Pekarskiy
T. M. Ripp
T. R. Ryabova
А. Yu. Falkovskaya
V. A. Lichikaki
I. V. Zyubanova
A. Е. Baev
A. M. Gusakova
author_facet E. S. Sitkova
V. F. Mordovin
S. E. Pekarskiy
T. M. Ripp
T. R. Ryabova
А. Yu. Falkovskaya
V. A. Lichikaki
I. V. Zyubanova
A. Е. Baev
A. M. Gusakova
author_sort E. S. Sitkova
collection DOAJ
description Aim. To study the long-term effect of renal denervation (RDN) on left ventricular mass (LVM) and inflammatory markers in resistant hypertensive patients.Material and methods. Forty-one patients with resistant hypertension and 24-h blood pressure (BP) 158,7±15,8/87,3+14,6 mmHg, aged 56,6+10,2 years, were enrolled in the study and undergone RDN. Mean 24-h BP, left ventricular mass (transthoracic echocardiography), high sensitivity C-reactive protein (hsCRP), interleukin- 1β (IL­1β), IL-6, IL-10) and tumor necrosis factor alpha (TNF- α) were assessed at baseline and 2 years after the RDN.Results. A baseline prevalence of left ventricular hypertrophy (LVH) was 90,2%. Two years after RDN LVM and interventricular septum (IVS) decreased significantly (p<0.05 for both). Decrease in myocardial mass (∆LVM >0 g) was documented in 24 patients. The regression of LVM was accompanied by a significant decrease in levels of inflammatory markers — hsCRP by 38,3% (p=0,031), TNF-α by 60,7% (p=0,009), IL- 1β — by 71,1% (p=0,001), and IL-10 by 58,2% (p=0,001). In patients in the absence of LVM regression only TNF-α decreased significantly (-68,8%, p=0,001). There was no correlation between changes of LVM and the inflammatory markers at 24 months after RDN.Conclusion. The RDN in RH patients may have long-term cardioprotective effect in terms of significant regress of LVH, which may be partly attributed to the regress in systemic or myocardial inflammation.
format Article
id doaj-art-45f95322aba4479fa14168049fd9830f
institution DOAJ
issn 1728-8800
2619-0125
language Russian
publishDate 2021-03-01
publisher «SILICEA-POLIGRAF» LLC
record_format Article
series Кардиоваскулярная терапия и профилактика
spelling doaj-art-45f95322aba4479fa14168049fd9830f2025-08-20T03:18:46Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252021-03-0120210.15829/1728-8800-2021-26782246Positive effects of renal denervation on markers of cardiovascular inflammation and left ventricular mass. 24-months follow-upE. S. Sitkova0V. F. Mordovin1S. E. Pekarskiy2T. M. Ripp3T. R. Ryabova4А. Yu. Falkovskaya5V. A. Lichikaki6I. V. Zyubanova7A. Е. Baev8A. M. Gusakova9Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of SciencesCardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of SciencesCardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of SciencesCardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of SciencesCardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of SciencesCardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of SciencesCardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of SciencesCardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of SciencesCardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of SciencesCardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of SciencesAim. To study the long-term effect of renal denervation (RDN) on left ventricular mass (LVM) and inflammatory markers in resistant hypertensive patients.Material and methods. Forty-one patients with resistant hypertension and 24-h blood pressure (BP) 158,7±15,8/87,3+14,6 mmHg, aged 56,6+10,2 years, were enrolled in the study and undergone RDN. Mean 24-h BP, left ventricular mass (transthoracic echocardiography), high sensitivity C-reactive protein (hsCRP), interleukin- 1β (IL­1β), IL-6, IL-10) and tumor necrosis factor alpha (TNF- α) were assessed at baseline and 2 years after the RDN.Results. A baseline prevalence of left ventricular hypertrophy (LVH) was 90,2%. Two years after RDN LVM and interventricular septum (IVS) decreased significantly (p<0.05 for both). Decrease in myocardial mass (∆LVM >0 g) was documented in 24 patients. The regression of LVM was accompanied by a significant decrease in levels of inflammatory markers — hsCRP by 38,3% (p=0,031), TNF-α by 60,7% (p=0,009), IL- 1β — by 71,1% (p=0,001), and IL-10 by 58,2% (p=0,001). In patients in the absence of LVM regression only TNF-α decreased significantly (-68,8%, p=0,001). There was no correlation between changes of LVM and the inflammatory markers at 24 months after RDN.Conclusion. The RDN in RH patients may have long-term cardioprotective effect in terms of significant regress of LVH, which may be partly attributed to the regress in systemic or myocardial inflammation.https://cardiovascular.elpub.ru/jour/article/view/2678resistant hypertensioncardioprotective efficacyleft ventricular hypertrophyrenal denervationinflammation
spellingShingle E. S. Sitkova
V. F. Mordovin
S. E. Pekarskiy
T. M. Ripp
T. R. Ryabova
А. Yu. Falkovskaya
V. A. Lichikaki
I. V. Zyubanova
A. Е. Baev
A. M. Gusakova
Positive effects of renal denervation on markers of cardiovascular inflammation and left ventricular mass. 24-months follow-up
Кардиоваскулярная терапия и профилактика
resistant hypertension
cardioprotective efficacy
left ventricular hypertrophy
renal denervation
inflammation
title Positive effects of renal denervation on markers of cardiovascular inflammation and left ventricular mass. 24-months follow-up
title_full Positive effects of renal denervation on markers of cardiovascular inflammation and left ventricular mass. 24-months follow-up
title_fullStr Positive effects of renal denervation on markers of cardiovascular inflammation and left ventricular mass. 24-months follow-up
title_full_unstemmed Positive effects of renal denervation on markers of cardiovascular inflammation and left ventricular mass. 24-months follow-up
title_short Positive effects of renal denervation on markers of cardiovascular inflammation and left ventricular mass. 24-months follow-up
title_sort positive effects of renal denervation on markers of cardiovascular inflammation and left ventricular mass 24 months follow up
topic resistant hypertension
cardioprotective efficacy
left ventricular hypertrophy
renal denervation
inflammation
url https://cardiovascular.elpub.ru/jour/article/view/2678
work_keys_str_mv AT essitkova positiveeffectsofrenaldenervationonmarkersofcardiovascularinflammationandleftventricularmass24monthsfollowup
AT vfmordovin positiveeffectsofrenaldenervationonmarkersofcardiovascularinflammationandleftventricularmass24monthsfollowup
AT sepekarskiy positiveeffectsofrenaldenervationonmarkersofcardiovascularinflammationandleftventricularmass24monthsfollowup
AT tmripp positiveeffectsofrenaldenervationonmarkersofcardiovascularinflammationandleftventricularmass24monthsfollowup
AT trryabova positiveeffectsofrenaldenervationonmarkersofcardiovascularinflammationandleftventricularmass24monthsfollowup
AT ayufalkovskaya positiveeffectsofrenaldenervationonmarkersofcardiovascularinflammationandleftventricularmass24monthsfollowup
AT valichikaki positiveeffectsofrenaldenervationonmarkersofcardiovascularinflammationandleftventricularmass24monthsfollowup
AT ivzyubanova positiveeffectsofrenaldenervationonmarkersofcardiovascularinflammationandleftventricularmass24monthsfollowup
AT aebaev positiveeffectsofrenaldenervationonmarkersofcardiovascularinflammationandleftventricularmass24monthsfollowup
AT amgusakova positiveeffectsofrenaldenervationonmarkersofcardiovascularinflammationandleftventricularmass24monthsfollowup